Trial Profile
Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary) ; Antidepressants
- Indications Depressive disorders; Dysthymic disorder; Insomnia
- Focus Therapeutic Use
- Acronyms STILDEP
- Sponsors Sanofi
- 15 Sep 2006 New trial record.